SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES: RESULTS OF A PROSPECTIVE EUROPEAN PROSTATE CANCER DETECTION STUDY-Reference-Cited by-同舟云学术

SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES: RESULTS OF A PROSPECTIVE EUROPEAN PROSTATE CANCER DETECTION STUDY

Published:2001-09 Issue:3 Volume:166 Page:856-860
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

DJAVAN BOB¹,WALDERT MATTHIAS¹,ZLOTTA ALEXANDRE¹,DOBRONSKI PIOTR¹,SEITZ CHRISTIAN¹,REMZI MESUT¹,BORKOWSKI ANDRZEJ¹,SCHULMAN CLAUDE¹,MARBERGER MICHAEL¹

Affiliation:

1. From the Departments of Urology, University Hospital of Vienna, Vienna, Austria, Warsaw Poland, and Brussels, Belgium

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference35 articles.

1. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate;Hodge;J Urol,1989

2. Detection of nonpalpable prostate cancer. A mathematical and laboratory model;Stricker;Br J Urol,1993

3. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study;Naughton;Urology,1998

4. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer;Levine;J Urol,1998

5. Clinical application of transrectal ultrasonography and prostate specific antigen in the search of prostate cancer;Cooner;J Urol,1988

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardized prostate cancer incidence and mortality rates following initial non‐malignant biopsy result;BJU International;2023-03-14

2. Prostate Cancer Diagnosis: Biopsy Approaches;Urologic Cancers;2022-09-12

3. Prostate cancer screening: Continued controversies and novel biomarker advancements;Current Urology;2022-08-31

4. Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications;Cancer Management and Research;2022-03

5. Diagnostic Applications of Nuclear Medicine: Prostatic Cancer;Nuclear Oncology;2022